Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Avalon Globocare Corp ALBT

Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering transformative, precision diagnostics and clinical laboratory services. The Company offers diagnostic testing utilizing proprietary technology to deliver genetics-driven results. It operates through two segments: Real property rental and Lab Services MSO. Lab Services MSO segment is focused on delivering... see more

Recent & Breaking News (NDAQ:ALBT)

Avalon's Laboratory Services MSO to Launch Sales of Proprietary FDA-Registered External Male Catheter Device

GlobeNewswire August 14, 2024

Avalon's Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction

GlobeNewswire July 31, 2024

Avalon GloboCare Launches Online Sales of KetoAir Breathalyzer in the U.S. at Ketoair.us

GlobeNewswire July 18, 2024

Avalon GloboCare Provides Update on the Launch of the KetoAir Breathalyzer at Hack Your Health by KetoCon 2024 Conference

GlobeNewswire June 20, 2024

Avalon GloboCare Receives Notice from Nasdaq Regarding Delayed Quarterly Report

GlobeNewswire May 24, 2024

Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference

GlobeNewswire April 22, 2024

Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union

GlobeNewswire March 28, 2024

Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US

GlobeNewswire December 18, 2023

Avalon GloboCare Partners with Qi Diagnostics to Co-Develop International Multi-Center Clinical Studies for DKAir Breathalyzer Device for the Early Detection of Diabetic Ketoacidosis

GlobeNewswire October 18, 2023

Apple Approves Use of Avalon GloboCare's KetoAir Mobile Application

GlobeNewswire October 4, 2023

Avalon's Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device

GlobeNewswire September 13, 2023

Avalon GloboCare Announces Notice of Publication for Key U.S. Patent Filed Jointly with the Massachusetts Institute of Technology (MIT)

GlobeNewswire September 5, 2023

Avalon's Laboratory Services MSO Launches Innovative Laboratory Test for Tuberculosis

GlobeNewswire August 30, 2023

Avalon's Laboratory Services MSO Announces Expansion into Arizona

GlobeNewswire August 21, 2023

Avalon's Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth

GlobeNewswire July 24, 2023

Avalon GloboCare's Laboratory Services MSO Signs Exclusive In-Network Lab Services Agreement Providing Significant Expansion Opportunity into 21 States

GlobeNewswire July 19, 2023

Avalon GloboCare Provides Update on New Commercial Strategy

GlobeNewswire July 10, 2023

Avalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022

GlobeNewswire April 27, 2023

Avalon GloboCare Announces Commercial Launch of KetoAir Breathalyzer at the KetoCon Austin 2023 Conference

GlobeNewswire April 17, 2023

Avalon GloboCare Signs Agreement with Qi Diagnostics to Exclusively Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, U.K. and European Union

GlobeNewswire April 11, 2023